CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403 | -25.9% | 4 | 0.0% | 0.00% | – |
| Q2 2023 | $544 | +31.1% | 4 | 0.0% | 0.00% | – |
| Q1 2023 | $415 | +16.9% | 4 | 0.0% | 0.00% | – |
| Q4 2022 | $355 | – | 4 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 4 | -55.6% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 9 | -10.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 10 | +150.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 4 | -50.0% | 0.00% | – |
| Q4 2020 | $0 | – | 8 | +100.0% | 0.00% | – |
| Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 4 | -33.3% | 0.00% | – |
| Q4 2019 | $1,000 | – | 6 | +100.0% | 0.00% | – |
| Q3 2019 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |